StockData
AstraZeneca PLC logo

AstraZeneca PLC (AZN) stock

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

AstraZeneca's pe ratio was 50.1× on Oct 19, 2026, against 73.2× a year earlier. Over the last 5 years it ranged from 46.9× to 138.8×, with a median of 71.0×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 19, 202650.1×−31.6
2025Dec 31, 202581.7×+12.9
2024Dec 31, 202468.8×−58.9
2023Dec 29, 2023127.7×+78.8
2017Jan 31, 201748.8×−0.2
2016Dec 30, 201649.0×–

More AstraZeneca figures

See a number that looks wrong?